http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112851914-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G59-5073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G59-5093
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G59-50
filingDate 2021-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-112851914-B
titleOfInvention A kind of composite modified 2-methylimidazole curing agent and preparation method thereof
abstract The invention discloses a composite modified 2-methylimidazole curing agent and a preparation method thereof, belonging to the field of fine chemicals. The preparation process of the composite modified curing agent is as follows: firstly, an intermediate product is prepared by reacting 2-methylimidazole and organic carbonate, and then the intermediate product is reacted with a metal salt to obtain a viscous liquid composite modified 2-methyl ester at room temperature. Imidazole curing agent. The organic carbonate is one of ethylene carbonate and propylene carbonate or a mixture of the two. The metal salt is a mixture composed of one or more of zinc acetate, copper acetate, zinc gluconate, and zinc sulfate heptahydrate. The composite modified curing agent of the invention has the advantages of easy mixing with epoxy resin, low reactivity under normal temperature conditions, excellent latent performance and high curing strength. In addition, the present invention utilizes organic carbonate to modify 2-methylimidazole, which belongs to the extension of carbon dioxide resource utilization technology.
priorityDate 2021-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BE-796764-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BE-837596-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520276
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453623101
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11192
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12749
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518788
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414871446
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452560574
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7303
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457698762
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID83699
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443445
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415745782
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15287
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421164088
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452327997
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62640
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7924
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69023
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408271913
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70262
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415777653
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID280

Total number of triples: 35.